GlassScriptPhysician profile
Phillip A Rodriguez
NPI 1043658867
$2,702.59
in general payments reported to CMS, 2019-2025
34 companies · $816 in 2025
The $816 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $151 · 2021: $331 · 2022: $449 · 2023: $301 · 2024: $274 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $328.02 | 2019-2025 | Orilissa |
| Daiichi Sankyo INC. | $271.45 | 2019-2025 | Injectafer |
| Hologic Sales and Service, LLC | $263.40 | 2019-2025 | Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Myosure Tissue Removal Device |
| Organon LLC | $249.15 | 2022-2025 | Nexplanon, Jada System |
| Astellas Pharma US INC | $237.86 | 2024-2025 | Veozah |
| Biogen, INC. | $176.90 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $117.83 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.83 | 2021-2025 | |
| Smith+Nephew, INC. | $95.37 | 2019-2025 | Pico, Pico 7 |
| Intuitive Surgical, INC. | $88.04 | 2019 | |
| Aspira Women'S Health INC | $78.45 | 2021 | |
| Exeltis, USA INC. | $63.59 | 2023-2025 | Slynd |
| Sumitomo Pharma America, INC. | $60.54 | 2025 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $54.89 | 2019-2023 | Exparel |
| Roche Diagnostics Corporation | $50.63 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $45.00 | 2023 | Femring, Intrarosa |
| Coopersurgical, INC. | $41.73 | 2021-2022 | |
| Therapeuticsmd, INC. | $35.76 | 2022 | |
| Alpha Orthopedic Systems | $34.85 | 2024 | |
| Convatec INC. | $32.82 | 2019-2021 | |
| Shield Therapeutics INC | $32.08 | 2023-2024 | Accrufer |
| Avanos Medical | $31.95 | 2019 | |
| Medtronic, INC. | $27.57 | 2022-2023 | Interstim |
| Evofem Biosciences, INC. | $26.19 | 2021 | |
| Optumhealth Care Solutions, LLC | $19.53 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Baxter Healthcare | $18.82 | 2025 | Perclot |
| Exact Sciences Corporation | $18.21 | 2023 | Cologuard Collection Kit |
| Minerva Surgical, INC | $17.57 | 2025 | |
| Ethicon US, LLC | $16.52 | 2025 | Dermabond Prineo, Vistaseal, Stratafix |
| Conmed Corporation | $14.66 | 2025 | Airseal |
| Gynesonics, INC. | $13.53 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Boston Scientific Corporation | $12.25 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.04 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.